STERIS faces earnings test as AST destocking questions persist By Investing.com

STERIS (NYSE: STE) is set to release its fiscal first-quarter earnings, with analysts anticipating $2.50 EPS on $1.5 billion revenue. Investors will be scrutinizing the Applied Sterilization Technologies (AST) segment for signs of stabilization after recent destocking. Analysts maintain a bullish outlook, with a mean price target of $255.38, suggesting a nearly 10% upside.